Use of benzodiazepines and risk of hip/femur fracture. A methodological comparison across data sources and epidemiological design.First published 04/09/2012 Last updated 22/02/2024 EU PAS number: EUPAS2385StudyOngoingDownload as PDF
Agencia Española de Medicamentos y Productos Sanitarios (Spanish Agency for Medicines and Medical Devices, AEMPS) First published: 01/02/2024Last updated 01/02/2024 InstitutionRegulatory AuthorityEU Institution/Body/AgencyNot-for-profit
Division of Pharmacoepidemiology & Clinical Pharmacology (PECP), Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht UniversityNetherlands First published: 01/03/2010Last updated 16/04/2024 InstitutionEducational InstitutionENCePP partner
Agencia Española de Medicamentos y Productos Sanitarios (Spanish Agency for Medicines and Medical Devices, AEMPS) First published: 01/02/2024Last updated 01/02/2024 InstitutionRegulatory AuthorityEU Institution/Body/AgencyNot-for-profit
PROTECTBelgiumDenmarkFranceGermanyItalyNetherlandsPolandSpainSwedenSwitzerlandUnited Kingdom First published: 26/06/2013Last updated 26/06/2013 NetworkENCePP partner